Bill117th CongressFiled Apr 7, 2022Health
H.R. 7473
Generic Substitution Noninterference Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Apr 7, 2022)
Generic Substitution Noninterference Act
This bill prohibits drug manufacturers from helping or directing health care providers to limit prescriptions to brand-name drugs when generic versions are available. The Federal Trade Commission and states may enforce this bill through civil actions.
What just happenedNov 1, 2022
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Who’s behind it
Rep. Maloney, Carolyn B. [D-NY-12](D-NY)Sponsor
7 cosponsors7 D
7cosponsors1committees4actions
- Introduced in HouseApr 7, 2022
- Nov 1, 2022Committee
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Administrative State, Regulatory Reform, and Antitrust Subcommittee - Apr 7, 2022IntroReferralH11100
Referred to the House Committee on the Judiciary.
Judiciary Committee - Apr 7, 2022IntroReferralIntro-H
Introduced in House
- Apr 7, 2022IntroReferral1000
Introduced in House